Table of contents
Volume 93, Issue 1
Published online 5 July 2005 (1-171)
Minireview
Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers FREE
P Mehlen and F Llambi
Br J Cancer 93: 1-6; advance online publication, June 14, 2005; doi:10.1038/sj.bjc.6602656
Clinical Studies
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients FREE
L Del Mastro, P Bruzzi, G Nicolò, G Cavazzini, A Contu, M D'Amico, A Lavarello, F Testore, B Castagneto, E Aitini, L Perdelli, C Bighin, R Rosso, Marco Venturini and other participants
Br J Cancer 93: 7-14; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602660
Soybean products and reduction of breast cancer risk: a case–control study in Japan FREE
K Hirose, N Imaeda, Y Tokudome, C Goto, K Wakai, K Matsuo, H Ito, T Toyama, H Iwata, S Tokudome and K Tajima
Br J Cancer 93: 15-22; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602659
Gefitinib is more effective in never-smokers with non-small-cell lung cancer: experience among Asian patients FREE
S-T Lim, E-H Wong, K-L Chuah, S-S Leong, W-T Lim, M-H Tay, C-K Toh and E-H Tan
Br J Cancer 93: 23-28; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602652
Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer FREE
F Cappuzzo, S Novello, F De Marinis, V Franciosi, M Maur, A Ceribelli, V Lorusso, F Barbieri, L Castaldini, E Crucitta, L Marini, S Bartolini, G V Scagliotti and L Crinò
Br J Cancer 93: 29-34; advance online publication, June 14, 2005; doi:10.1038/sj.bjc.6602667
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma FREE
C Bengala, V Guarneri, E Giovannetti, M Lencioni, E Fontana, V Mey, A Fontana, U Boggi, M Del Chiaro, R Danesi, S Ricci, F Mosca, M Del Tacca and P F Conte
Br J Cancer 93: 35-40; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602673
A randomised controlled trial of nurse-managed trial conclusion following early phase cancer trial participation FREE
K Cox, E Wilson, A Arthur, R Elkan and S Armstrong
Br J Cancer 93: 41-45; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602675
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar FREE
P M Fracasso, K A Blum, M K Ma, B R Tan, L P Wright, S A Goodner, C L Fears, W Hou, M A Arquette, J Picus, A Denes, J E Mortimer, L Ratner, S P Ivy and H L McLeod
Br J Cancer 93: 46-53; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602653
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours FREE
R T Penson, M V Seiden, U A Matulonis, L J Appleman, A F Fuller Jr, A Goodman, S M Campos, J W Clark, M Roche and J P Eder Jr
Br J Cancer 93: 54-59; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602671
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer FREE
N C Levitt, D J Propper, S Madhusudan, J P Braybrooke, C Echeta, R te Poele, S L Davies, E Flanagan, I D Hickson, S Joel and T S Ganesan
Br J Cancer 93: 60-69; advance online publication, June 14, 2005; doi:10.1038/sj.bjc.6602657
Translational Therapeutics
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells FREE
M Amit-Vazina, S Shishodia, D Harris, Q Van, M Wang, D Weber, R Alexanian, M Talpaz, B B Aggarwal and Z Estrov
Br J Cancer 93: 70-80; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602637
Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts FREE
L Eikenes, M Tari, I Tufto, Ø S Bruland and C de Lange Davies
Br J Cancer 93: 81-88; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602626
The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines FREE
D Kostrzewa-Nowak, M J I Paine, C R Wolf and J Tarasiuk
Br J Cancer 93: 89-97; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602639
The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification FREE
M Cemazar, I Wilson, V E Prise, K M Bell, S A Hill and G M Tozer
Br J Cancer 93: 98-106; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602672
Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer FREE
L Gibault, J-P Metges, V Conan-Charlet, P Lozac'h, M Robaszkiewicz, C Bessaguet, N Lagarde and A Volant
Br J Cancer 93: 107-115; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602625
Molecular Diagnostics
Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability FREE
T Maeda, H Tashiro, H Katabuchi, M Begum, H Ohtake, T Kiyono and H Okamura
Br J Cancer 93: 116-123; advance online publication, June 14, 2005; doi:10.1038/sj.bjc.6602662
Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas FREE
L M Bäcklund, B R Nilsson, L Liu, K Ichimura and V P Collins
Br J Cancer 93: 124-130; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602661
Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma FREE
A Toma, E Otsuji, Y Kuriu, K Okamoto, D Ichikawa, A Hagiwara, H Ito, T Nishimura and H Yamagishi
Br J Cancer 93: 131-136; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602668
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients FREE
G-B Qiao, Y-L Wu, X-N Yang, W-Z Zhong, D Xie, X-Y Guan, D Fischer, H-C Kolberg, S Kruger and H-W Stuerzbecher
Br J Cancer 93: 137-143; advance online publication, June 14, 2005; doi:10.1038/sj.bjc.6602665
Expression of pendrin in benign and malignant human thyroid tissues FREE
J Skubis-Zegad
o, A Nikodemska, E Przytua, M Mikula, K Bardadin, J Ostrowski, B E Wenzel and B Czarnocka
Br J Cancer 93: 144-151; advance online publication, June 7, 2005; doi:10.1038/sj.bjc.6602628
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete FREE
A Yannopoulos, E Dimitriadis, A Scorilas, T Trangas, E Markakis and M Talieri
Br J Cancer 93: 152-158; advance online publication, June 28, 2005; doi:10.1038/sj.bjc.6602642
Epidemiology
Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma FREE
P Brennan, G Scélo, K Hemminki, L Mellemkjaer, E Tracey, A Andersen, D H Brewster, E Pukkala, M L McBride, E V Kliewer, J M Tonita, A Seow, V Pompe-Kirn, C Martos, J G Jonasson, D Colin and P Boffetta
Br J Cancer 93: 159-166; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602654
No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype FREE
S E Bojesen, A Tybjærg-Hansen, C K Axelsson and B G Nordestgaard
Br J Cancer 93: 167-171; advance online publication, June 21, 2005; doi:10.1038/sj.bjc.6602674
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
